Natural Capsules Ltd

Natural Capsules Ltd — Trading Window closed from October 01, 2026 until 48 hours after the declaration of financial results for the quarter ended September 30, 2026.

Resolution 1: Preferential equity issue

• Type: Special; Nature: Issuance of equity shares on a preferential basis.
• Key terms: Preferential allotment; number and price not disclosed.
• Promoters/directors: Not disclosed.
• Voting outcome: Approved; 34 in favour, 3 against (99.994%).

Resolution 2: Preferential warrants issue

• Type: Special; Nature: Issuance of warrants convertible into equity on a preferential basis.
• Key terms: Warrants issued on preferential basis; quantities and price not disclosed.
• Promoters/directors: Not disclosed.
• Voting outcome: Approved; 33 in favour, 4 against (99.993%).

Impact on shareholding

• Impact on shareholding: Post-issue ownership details not provided.

Resolutions

• Special Resolution: preferential allotment of equity shares (terms undisclosed in excerpt).
• Special Resolution: preferential warrants convertible into equity shares (terms undisclosed in excerpt).
• Voting results pending Scrutinizer's report; will be announced separately.
• Promoter/director participation not disclosed in excerpt.

Impact on shareholding

• Details on dilution or promoter holdings not disclosed.

Utilisation of funds / objects

• Use of proceeds not disclosed in this excerpt.

Board / management

• No changes to board or KMPs disclosed.

Corrigendum & EGM details

• Corrigendum dispatched for EGM dated Sep 9, 2026.
• Equity: 1,12,500 shares at ₹178; Warrants: 4,50,000 at ₹178.
• Pricing date for terms: 10 August 2026.
• Minimum price for preferential issue: ₹177 per share.
• Board approved revision of price/quantity on Sep 2, 2026.
• Corrigendum and disclosures available on the company's website.

Equity preferential issue

• Proposed allottee: Sunil Laxminarayan Mundra (Promoter – Individual).
• Issue size: 1,12,500 equity shares; ₹2,00,25,000 total.
• Use of proceeds: Working capital ₹1.80 Cr; Capital expansion ₹0.20 Cr.
• Board approval date for revised terms: 2 Sep 2026.

Warrant preferential issue

• Proposed allottee: Sunil Mundra; 4,50,000 warrants at ₹178 each.
• Warrants convertible into 1 equity share; 18-month tenure.
• 25% upfront, 75% on exercise.
• Proceeds from warrants: ₹8,01,00,000; all for Working Capital.
• Promoter Mundra post-issuance holding: 10.61%.
• Overall promoter stake after issue: 53.44%.
• Minimum price ₹177 per share; valuation dated Aug 31, 2026.
• Pricing certificate dated Sep 2, 2026.

Capital raise and pricing

• Approved preferential issue up to 1,12,500 equity shares at ₹178 each.
• Approved 4,50,000 warrants at ₹178 each, convertible into equity shares.
• Subject to member approval and regulatory clearances.
• Pricing/quantities revised per August 31, 2026 valuation.

EGM corrigendum and shorter notice

• Corrigendum for EGM on Sept 9, 2026 to be dispatched Sept 2, 2026.
• Shorter notice due to late valuation; director consents obtained.
• Valuation report dated Aug 31, 2026; queries from BSE/NSE.
• Meeting held Sept 2, 2026, 9:00–11:00 AM.

Shareholding impact and warrants terms

• Post-issue promoter holding: 6,02,290 shares, 5.79%.
• Assuming full warrant conversion, promoter stake 11,64,790 shares, 10.61%.
• Warrants exercisable within 18 months; 25% upfront, 75% on equity share allotment.
• Balance payable amounts and conversion subject to SEBI ICDR rules.

Regulatory disclosures

• Annexure A contains disclosures under Regulation 30 of the Listing Regulations.
• Minimum ₹44.50 upfront per warrant; 25% upfront payment requirement.